Harnessing the potential of cancer genetics in healthcare

Lancet Oncology

Volumn 5, Issue 10, 2004, Pages 626-632

  Pichert, Gabriella ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CANCER THERAPY; COMMUNITY; FAMILY; HEALTH CARE; HEALTH CARE QUALITY; HUMAN; MEDICAL ETHICS; MEDICOLEGAL ASPECT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SOCIAL ASPECT;

GENETIC SCREENING; GREAT BRITAIN; HUMANS; NATIONAL HEALTH PROGRAMS; NEOPLASMS;

EID: 4644227706     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(04)01598-0     Document Type: Review

References (44)

1. Slattery ML. Kerber RA. A comprehensive evaluation of family history and breast cancer risk JAMA 270 1993 1563-1568
2. Colditz GA. Willett WC. Hunter DJ. et al. Family history, age and risk of breast cancer JAMA 270 1993 338-343
3. Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndromes N Engl J Med 331 1994 1694-1770
4. UK Department of Health. Our inheritance, our future: realising the potential of genetics in the NHS. Genetics Branch, UK Department of Health, June, 2003. http://www.doh.gov.uk/genetics/whitepaper.htm (accessed Sept 13, 2004).
5. Galjaard H. Antenatal diagnosis of fetal abnormalities 1991 297-310 Springer-Verlag Berlin
6. Secretary's advisory committee on genetic testing. Enhancing the oversight of genetic tests: recommendations of the Secretary's advisory committee on genetic testing. Bethesda: National Institutes of Health, 2000. http://www4.od.nih.gov/oba/sacgt.htm (accessed March 17, 2004).
7. National Health and Medical Research Council. Ethical aspects of human genetic testing: an information paper. Canberra: Commonwealth of Australia, 2000. http://www.health.gov.au/nhmrc/publications/ synopses/e39syn.htm (accessed Sept 13, 2004).
8. UK Human Genetics Commission. Balancing interests in the use of human genetic data. http://www.hgc.gov.uk/insideinformation/index.htm (accessed March 17, 2004).
9. American Society of Clinical Oncology. Genetic testing for cancer susceptibility, adopted on February 20, 1996 J Clin Oncol 14 1996 1730-1736
10. National Advisory Council for the Human Genome Research. Statement on the use of DNA testing for presymptomatic identification of cancer risk JAMA 271 1994 785
11. Genetic testing and screening in the age of genomic medicine. New York: New York State Task Force on Life and the Law, 2000: 98.
12. Swiss Federal Department of Justice. Bundesgesetz über genetische Untersuchungen am Menschen. http://www.ofj.admin.ch/themen/genomanalyse/ vn-ve-d.pdf (accessed Sept, 2004, in German).
13. Lucassen A. Watson E. Harcourt J. et al. Guidelines for referral to regional genetics service. GPs respond by referring more appropriate cases Fam Pract 18 2001 135-140
14. Eccles DM. Evans DGR. Mackay J. et al. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer J Med Genetic 37 2000 203-209
15. Working Group for the Chief Medical Officer Genetics and Cancer Services. Report of a working group for the Chief Medical Officer, Department of Health 1998 Department of Health London
16. Pichert G. Dietrich D. Moosmann P. et al. Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer Fam Cancer 2 2003 153-158
17. Watson EK. Shickle D. Qureshi N. et al. The "new genetics" and primary care: GP's view on their role and their educational needs Fam pract 16 1999 420-429
18. Fry A. Campbell H. Gudmondsdottir H. et al. GP's views on their role in cancer genetics services and current practice Fam pract 16 1999 468-474
19. Acheson LS. Wiesner GL. Zyzanski SJ. et al. Family history taking in community family practice: implications for genetic screening Genet Med 2 2000 180-185
20. Worthen H. Inherited cancer and the primary care physician Cancer 86 suppl 1999 S2583-S2588
21. Hayflick SJ. Eiff P. Carpenter L. et al. Primary care physicians utilization and perception of genetics services Genet Med 1 1998 13-21
22. Hofman KJ. Tambor ES. Chase GA. et al. Physicians knowledge of genetics and genetic tests Acad Med 688 1993 625-632
23. Watson E. Clements A. Yudkin P. et al. Evaluation of the impact of two educational interventions on management of familial breast/ovarian cancer cases:s clustered rendomized controlled trial Br J Gen Pract 51 2001 817-821
24. De Bock GH. van Asperen CJ. de Vries JM. et al. How women with a family history of breast cancer and their general practitioners act on genetic advice in general practice: prospective longitudinal study BMJ 7277 2001 26-27
25. De Bock GH. Vlieland TP. Hakkeling M. et al. GP's management of women seeking help for familial breast cancer Fam Pract 16 1999 463-467
26. Rose PW. Watson E. Yudkin P. et al. Referral of patients with a family history of breast/ovarian cancer-GPs knowledge and expectations Fam Pract 18 2001 487-490
27. Olopade OI. Pichert G. Cancer genetics in oncology practice Ann Oncol 12 2001 895-908
28. Wonderling D. Hopwood P. Cull A. et al. A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics Br J Cancer 85 2001 166-170
29. Sobol H. Bignon YJ. Bonaiti C. et al. Four years analysis of Cancer Genetic Clinics. Activity in France from 1994-97: a survey on 801 patients Dis Markers 15 1999 15-29
30. Gronwald J. Menkiszak J. Huzarski T. et al. Clinical genetic services for familial breast cancer in Poland Dis Markers 15 1999 75-77
31. Menko FH. Familial breast cancer: clinical services in the Netherlands Dis Markers 15 1999 31-33
32. Hodgson SV. Cancer genetics services in the UK Dis Markers 15 1999 44-45
33. Pichert G. Stahel RA Organizing cancer genetics programs: the Swiss model Clin Oncol 18 suppl 2000 S65-S69
34. Schmutzler R. Schlegelberger B. Meindl A. et al. Conselling, genetic testing and prevention in women with hereditary breast and ovarian cancer Zentralbl Gynakol 125 2003 494-506
35. Le ministre de la santé, de la famille et des personnes handicappés. Circulaire DHOS/SDO/No 2003/292 of June 23, 2003. http://www.sante.gouv.fr/htm/dossiers/cancer (accessed Sept 13, 2004, in French).
36. Emery J. Lucassen A. Murphy M. Common hereditary cancers and implications for primary care Lancet 358 2001 56-63
37. Parker M. Lucassen A. Working towards ethical management of genetic testing Lancet 360 2002 1685-1688
38. Cullen J. Schwartz MD. Lawrence WF. et al. Short-term impact of cancer prevention and screening activities on quality of life J Clin Oncol 22 2004 943-952
39. Steel M. Smyth E. Vasen H. et al. Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC Biomed II Demonstration Project Dis Markers 15 1999 125-131
40. Macmillan Cancer Relief and the UK Department of Health. Invitation to bid for funding to pilot the development of cancer genetics services: risk assessment and counselling. http://www.macmillan.org.uk/healthprofessionals/disppage (accessed March 17, 2004).
41. BBC News Health. Patients get "cancer-gene advice". http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/3503139.stm (accessed Sept 13, 2004).
42. The Breast Cancer Linkage Consortium. http://www.humgen.nl/ lab-devilee/bclchome.htm (accessed September 13, 2004).
43. CORDIS: Life sciences, genomics and biotechnology for health. 6th Framework programme for research and development of the European Union. http://www.cordis.lu/lifescihealth/home.html (accessed Sept 13, 2004).
44. UK National Institute for Clinical Excellence. Familial breast cancer: classification and care of women at risk of familial breast cancer in primary, secondary care and tertiary care. http://www.nice.org.uk/article.asp?a=30600 (accessed Sept 13, 2004).